Igene Biotechnology, Inc.
IGNE - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$15.65K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $15,654.00 |
|---|---|
| Enterprise Value | $7.08 Million |
| Earnings per Share | $0 |
| Beta | 0.17 |
| Outstanding Shares | 1,565,404,297 |
Return
| Return on Equity | 50.66% |
|---|---|
| Return on Assets | -69.56% |
| Return on Invested Capital | -46.51% |
Valuation & Multiples
| P/E Ratio | -0.1 |
|---|---|
| PEG | 0.02 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 1474.2 |
| Enterprise Value to EBIT | -11.87 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 1.04 |
| Debt to Equity | -1.57 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Igene Biotechnology, Inc.
18 employees
CEO: Joseph L. Downs
Igene Biotechnology, Inc. is dedicated to the discovery, development, production, and commercialization of specialized ingredients for both human and animal nutrition. A key offering from the company is natural astaxanthin, a valuable nu...